How to Design a Cell or Gene Therapy Clinical Trial: Advice From the FDA

Molecular Therapy - United States
doi 10.1038/mt.2013.172
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

FDA Oversight of Cell Therapy Clinical Trials

Science Translational Medicine
Medicine
2012English

880. Hematopoietic Stem Cell Gene Therapy for the Treatment of Metachromatic Leukodystrophy: Clinical Trial Design

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2008English

Clinical Trial Evidence Supporting FDA Approval of Drugs Granted Breakthrough Therapy Designation

JAMA - Journal of the American Medical Association
Medicine
2018English

Gene Therapy for Pain: Results of a Phase I Clinical Trial

Annals of Neurology
Neurology
2011English

Manual Therapy, Exercise Therapy, or Both, in Addition to Usual Care, for Osteoarthritis of the Hip or Knee: A Randomized Controlled Trial. 1: Clinical Effectiveness

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2013English

The ACTIVE Trial: To Continue or Not? How to Answer the Question

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Challenges in Vector and Trial Design Using Retroviral Vectors for Long-Term Gene Correction in Hematopoietic Stem Cell Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Advice From Cell Press Reviewers

Cell
BiochemistryGeneticsMolecular Biology
2019English

Equitable Access to Gene Therapy: A Call to Action for the American Society of Gene and Cell Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy